ÉTUDE PRODIGE 41-FFCD-BEVANEC - Recrutement terminé/suivi

NCT02820857

Title

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer

Coordonateur

WALTER T

Co-Coordonateur

MALKA D

Promoteur

HOSPICES CIVILS DE LYON (HCL)

Localisation

Néoplasie Neuroendocrine

Phase

IIR

NOMBRE DE PATIENTS ATTENDU

145

Statut

Recrutement terminé/suivi

CONTACT

c-dumasbonnetain@unicancer.fr